XTL Biopharmaceuticals Ltd is a biotechnology business based in the US. XTL Biopharmaceuticals shares (XTLB) are listed on the NASDAQ and all prices are listed in US Dollars.
How to buy shares in XTL Biopharmaceuticals
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – XTLB – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
XTL Biopharmaceuticals stock price (NASDAQ: XTLB)Use our graph to track the performance of XTLB stocks over time.
XTL Biopharmaceuticals shares at a glance
|Latest market close||$3.98|
|52-week range||$2.00 - $6.69|
|50-day moving average||$4.33|
|200-day moving average||$3.76|
|Wall St. target price||$30.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.60|
Buy XTL Biopharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy XTL Biopharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
XTL Biopharmaceuticals price performance over time
|1 week (2021-10-12)||-1.49%|
|1 month (2021-09-20)||-3.63%|
|3 months (2021-07-20)||9.34%|
|6 months (2021-04-20)||32.67%|
|1 year (2020-10-19)||96.06%|
|2 years (2019-10-16)||N/A|
|3 years (2018-10-19)||54.86%|
|5 years (2016-10-18)||322.55%|
XTL Biopharmaceuticals financials
|Gross profit TTM||$0|
|Return on assets TTM||-9.18%|
|Return on equity TTM||-58.46%|
|Market capitalisation||$20.8 million|
TTM: trailing 12 months
Shorting XTL Biopharmaceuticals shares
There are currently 20,197 XTL Biopharmaceuticals shares held short by investors – that's known as XTL Biopharmaceuticals's "short interest". This figure is 1.1% up from 19,971 last month.
There are a few different ways that this level of interest in shorting XTL Biopharmaceuticals shares can be evaluated.
XTL Biopharmaceuticals's "short interest ratio" (SIR)
XTL Biopharmaceuticals's "short interest ratio" (SIR) is the quantity of XTL Biopharmaceuticals shares currently shorted divided by the average quantity of XTL Biopharmaceuticals shares traded daily (recently around 84154.166666667). XTL Biopharmaceuticals's SIR currently stands at 0.24. In other words for every 100,000 XTL Biopharmaceuticals shares traded daily on the market, roughly 240 shares are currently held short.
However XTL Biopharmaceuticals's short interest can also be evaluated against the total number of XTL Biopharmaceuticals shares, or, against the total number of tradable XTL Biopharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case XTL Biopharmaceuticals's short interest could be expressed as 0% of the outstanding shares (for every 100,000 XTL Biopharmaceuticals shares in existence, roughly 0 shares are currently held short) or 0.0058% of the tradable shares (for every 100,000 tradable XTL Biopharmaceuticals shares, roughly 6 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against XTL Biopharmaceuticals.
Find out more about how you can short XTL Biopharmaceuticals stock.
XTL Biopharmaceuticals share dividends
We're not expecting XTL Biopharmaceuticals to pay a dividend over the next 12 months.
Have XTL Biopharmaceuticals's shares ever split?
XTL Biopharmaceuticals's shares were split on a 1:5 basis on 9 February 2017. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your XTL Biopharmaceuticals shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for XTL Biopharmaceuticals shares which in turn could have impacted XTL Biopharmaceuticals's share price.
XTL Biopharmaceuticals share price volatility
Over the last 12 months, XTL Biopharmaceuticals's shares have ranged in value from as little as $2.0001 up to $6.69. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while XTL Biopharmaceuticals's is 0.9929. This would suggest that XTL Biopharmaceuticals's shares are less volatile than average (for this exchange).
XTL Biopharmaceuticals overview
XTL Biopharmaceuticals Ltd. , a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. Its lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. XTL Biopharmaceuticals Ltd. has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals in the news
Dr. Morris C. Laster Files Preliminary Proxy Statement Nominating Two Highly-Qualified Individuals For Election To Board At Scopus BioPharma Inc.'s 2021 Annual Meeting
Frequently asked questionsWhat percentage of XTL Biopharmaceuticals is owned by insiders or institutions?
Currently 19.286% of XTL Biopharmaceuticals shares are held by insiders and 9.541% by institutions. When does the fiscal year end for XTL Biopharmaceuticals?
XTL Biopharmaceuticals's fiscal year ends in December. Where is XTL Biopharmaceuticals based?
XTL Biopharmaceuticals's address is: 5 Badner Street, Ramat Gan, Israel, 5218102 What is XTL Biopharmaceuticals's ISIN number?
XTL Biopharmaceuticals's international securities identification number is: US98386D3070 What is XTL Biopharmaceuticals's CUSIP number?
XTL Biopharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 98386D109
More guides on Finder
How to buy Aura Biosciences (AURA) stock when it goes public
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
How to buy Claros Mortgage Trust (CMTG) stock when it goes public
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
How to buy Evotec SE (EVO) stock when it goes public
Everything we know about the Evotec SE IPO, plus information on how to buy in.
How to buy Delimobil Holding SA (DMOB) stock when it goes public
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
How to buy Blue Water Vaccines (BWV) stock when it goes public
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
How to buy Sonendo (SONX) stock when it goes public
Everything we know about the Sonendo IPO, plus information on how to buy in.
How to buy FlexEnergy Green Solutions (FLXE) stock when it goes public
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
How to buy Stran & Company (STRN) stock when it goes public
Everything we know about the Stran & Company IPO, plus information on how to buy in.
How to buy Kidpik Corp (PIK) stock when it goes public
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
How to buy Nuvectis Pharma (NVCT) stock when it goes public
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
Ask an Expert